RxDoctor Payments Data

Tyson Corbin, PA

Physician Assistant · Springfield, ILNPI 1336407378

Payments from drug & device makers

$4,588in general payments, 2019–2025

Across 233 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$665
  • Johnson & Johnson$427
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$276
  • Aimmune Therapeutics, Inc.$230
  • Madrigal Pharmaceuticals$208
  • plus $969 from 15 others

What the payments were for

  • Food & beverage$4,36395%
  • Education$2255%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,588 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$49,460
Medicare patients
414
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase16$106,041
ZenpepLipase/Protease/Amylase20$104,570
LinzessLinaclotide65$64,196
Mesalamine ErMesalamine17$6,100
Dexlansoprazole DrDexlansoprazole11$6,045
Esomeprazole Magnesium63$2,443
Pantoprazole Sodium211$1,896
Sucralfate17$1,373
Famotidine138$1,161
Dicyclomine Hcl71$1,158
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates17$981
Omeprazole70$740
Lactulose17$289
Sulfasalazine11$266
Amitriptyline Hcl14$48

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,813$170,23781 claims
Aimmune Therapeutics, Inc.Zenpep$230$104,57020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →